glenmark-pharmaceuticals-ltd

Home

breadcrumb-icon
company logo

Glenmark Pharmaceuticals Ltd

GLENMARK Share Price

BSE:

NSE:GLENMARK

-

0 (0%)

Market Cap

42,813.59 Cr


Glenmark Pharmaceuticals Ltd Performance

-

-

-

-

-

-

-

-

Glenmark Pharmaceuticals Ltd Fundamentals

Read More

42,813.59Cr

0

5.07

0.34

0

0.16%

299.29

Glenmark Pharmaceuticals Ltd Futures

Monthly Contracts Days For Expiry Last Traded Price Volume
Glenmark Pharmaceuticals Ltd 26 Dec 2024111519.354152
Glenmark Pharmaceuticals Ltd 30 Jan 2025461527.05762
Glenmark Pharmaceuticals Ltd 27 Feb 20257415508

Glenmark Pharmaceuticals Ltd Options Snapshot

Glenmark Pharmaceuticals Ltd Shareholding Pattern

Glenmark Pharmaceuticals Ltd Delivery and Volume

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical product

Glenn Saldanha

1977

GLENMARK

NameDesignation
Glenn SaldanhaChairman & Managing Director
Gracias SaldanhaChairman
Cheryl PintoExecutive Director (Corporate)
V S ManiExecutive Director & Group CFO
B E SaldanhaNon Executive Director
Julio F RibeiroDirector
Natvarlal B DesaiDirector
Rajesh Desai.Independent Non Exe. Director
M Gopal KrishnanDirector
Sridhar GorthiDirector
Sona Saira RamasastryIndependent Non Exe. Director
A S MohantyDirector
M J MendonzaCompany Secretary
Dipankar BhattacharjeeIndependent Non Exe. Director
Sanjay ChowdharyJoint Company Secretary
V R IyerIndependent Non Exe. Director
D R MehtaAdditional Director
News and Events...

Top Gainers Today

View All

Top Losers Today

View All

Glenmark Pharmaceuticals Ltd FAQs

How do I Buy Glenmark Pharmaceuticals Ltd Shares?

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glenmark Pharmaceuticals Ltd shares in BlinkX.

What is the Share Price of Glenmark Pharmaceuticals Ltd?

The share price of any stock is volatile and changes during the day due to a variety of variables. Glenmark Pharmaceuticals Ltd's share price is ₹1518.15 as of 2024-12-15.

What is the PE ratio of Glenmark Pharmaceuticals Ltd?

Glenmark Pharmaceuticals Ltd's P/E ratio is - times as of 2024-12-15.

What is the PB ratio of Glenmark Pharmaceuticals Ltd?

Glenmark Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 5.07, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Glenmark Pharmaceuticals Ltd?

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glenmark Pharmaceuticals Ltd's market capitalization is ₹42813.59 Cr as on 2024-12-15.

What is the ROE of Glenmark Pharmaceuticals Ltd?

The current financial records of Glenmark Pharmaceuticals Ltd show a 6.98% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Glenmark Pharmaceuticals Ltd?

According to Glenmark Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹5157.09, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Glenmark Pharmaceuticals Ltd?

The 52-week high/low price of a Glenmark Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glenmark Pharmaceuticals Ltd's 52-week high and low as of 2024-12-15 are ₹1543.95 and ₹1446.5, respectively.

What's Trending

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions